Brief: Organogenesis Q1 Net Product Revenue USD 36.3 Million
07/05/2026 21:05
May 07 (Reuters) - Organogenesis Q1 net income USD -53.2 million. Q1 adjusted net income USD -43.7 million Q1 operating income USD -68.9 million Q1 adjusted EBITDA USD -48.2 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers